The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Transcatheter Pulmonary Valve Market Research Report 2025
Synopsis
The global Transcatheter Pulmonary Valve market was valued at US$ 32 million in 2023 and is anticipated to reach US$ 41 million by 2030, witnessing a CAGR of 3.4% during the forecast period 2024-2030.
North American market for Transcatheter Pulmonary Valve is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Transcatheter Pulmonary Valve is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Transcatheter Pulmonary Valve in Cardiac Anomaly is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Transcatheter Pulmonary Valve include Boston Scientific Corporation, Braile Biomédica, Direct Flow Medical, Edwards Lifesciences Corporation, JenaValve Technology, Inc., Abbott, SYMETIS (Boston Scientific), Colibri Heart Valve, LLC and VENUS MEDTECH, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Transcatheter Pulmonary Valve, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Transcatheter Pulmonary Valve.
Report Scope
The Transcatheter Pulmonary Valve market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Transcatheter Pulmonary Valve market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Transcatheter Pulmonary Valve companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Boston Scientific Corporation
Braile Biomédica
Direct Flow Medical
Edwards Lifesciences Corporation
JenaValve Technology, Inc.
Abbott
SYMETIS (Boston Scientific)
Colibri Heart Valve, LLC
VENUS MEDTECH
XELTIS
Segment by Type
Balloon-Expanded
Self-Expanded
Segment by Application
Cardiac Anomaly
Pulmonary Atresia
Pulmonary Stenosis
Pulmonary Regurgitation
Tetralogy of Fallot
Truncus Arteriosus
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Transcatheter Pulmonary Valve companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global Transcatheter Pulmonary Valve market was valued at US$ 32 million in 2023 and is anticipated to reach US$ 41 million by 2030, witnessing a CAGR of 3.4% during the forecast period 2024-2030.
North American market for Transcatheter Pulmonary Valve is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Transcatheter Pulmonary Valve is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Transcatheter Pulmonary Valve in Cardiac Anomaly is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Transcatheter Pulmonary Valve include Boston Scientific Corporation, Braile Biomédica, Direct Flow Medical, Edwards Lifesciences Corporation, JenaValve Technology, Inc., Abbott, SYMETIS (Boston Scientific), Colibri Heart Valve, LLC and VENUS MEDTECH, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Transcatheter Pulmonary Valve, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Transcatheter Pulmonary Valve.
Report Scope
The Transcatheter Pulmonary Valve market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Transcatheter Pulmonary Valve market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Transcatheter Pulmonary Valve companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Boston Scientific Corporation
Braile Biomédica
Direct Flow Medical
Edwards Lifesciences Corporation
JenaValve Technology, Inc.
Abbott
SYMETIS (Boston Scientific)
Colibri Heart Valve, LLC
VENUS MEDTECH
XELTIS
Segment by Type
Balloon-Expanded
Self-Expanded
Segment by Application
Cardiac Anomaly
Pulmonary Atresia
Pulmonary Stenosis
Pulmonary Regurgitation
Tetralogy of Fallot
Truncus Arteriosus
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Transcatheter Pulmonary Valve companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Transcatheter Pulmonary Valve Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Balloon-Expanded
1.2.3 Self-Expanded
1.3 Market by Application
1.3.1 Global Transcatheter Pulmonary Valve Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Cardiac Anomaly
1.3.3 Pulmonary Atresia
1.3.4 Pulmonary Stenosis
1.3.5 Pulmonary Regurgitation
1.3.6 Tetralogy of Fallot
1.3.7 Truncus Arteriosus
1.3.8 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Transcatheter Pulmonary Valve Market Perspective (2019-2030)
2.2 Transcatheter Pulmonary Valve Growth Trends by Region
2.2.1 Global Transcatheter Pulmonary Valve Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Transcatheter Pulmonary Valve Historic Market Size by Region (2019-2024)
2.2.3 Transcatheter Pulmonary Valve Forecasted Market Size by Region (2025-2030)
2.3 Transcatheter Pulmonary Valve Market Dynamics
2.3.1 Transcatheter Pulmonary Valve Industry Trends
2.3.2 Transcatheter Pulmonary Valve Market Drivers
2.3.3 Transcatheter Pulmonary Valve Market Challenges
2.3.4 Transcatheter Pulmonary Valve Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Transcatheter Pulmonary Valve Players by Revenue
3.1.1 Global Top Transcatheter Pulmonary Valve Players by Revenue (2019-2024)
3.1.2 Global Transcatheter Pulmonary Valve Revenue Market Share by Players (2019-2024)
3.2 Global Transcatheter Pulmonary Valve Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Transcatheter Pulmonary Valve Revenue
3.4 Global Transcatheter Pulmonary Valve Market Concentration Ratio
3.4.1 Global Transcatheter Pulmonary Valve Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Transcatheter Pulmonary Valve Revenue in 2023
3.5 Transcatheter Pulmonary Valve Key Players Head office and Area Served
3.6 Key Players Transcatheter Pulmonary Valve Product Solution and Service
3.7 Date of Enter into Transcatheter Pulmonary Valve Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Transcatheter Pulmonary Valve Breakdown Data by Type
4.1 Global Transcatheter Pulmonary Valve Historic Market Size by Type (2019-2024)
4.2 Global Transcatheter Pulmonary Valve Forecasted Market Size by Type (2025-2030)
5 Transcatheter Pulmonary Valve Breakdown Data by Application
5.1 Global Transcatheter Pulmonary Valve Historic Market Size by Application (2019-2024)
5.2 Global Transcatheter Pulmonary Valve Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Transcatheter Pulmonary Valve Market Size (2019-2030)
6.2 North America Transcatheter Pulmonary Valve Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Transcatheter Pulmonary Valve Market Size by Country (2019-2024)
6.4 North America Transcatheter Pulmonary Valve Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Transcatheter Pulmonary Valve Market Size (2019-2030)
7.2 Europe Transcatheter Pulmonary Valve Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Transcatheter Pulmonary Valve Market Size by Country (2019-2024)
7.4 Europe Transcatheter Pulmonary Valve Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Transcatheter Pulmonary Valve Market Size (2019-2030)
8.2 Asia-Pacific Transcatheter Pulmonary Valve Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Transcatheter Pulmonary Valve Market Size by Region (2019-2024)
8.4 Asia-Pacific Transcatheter Pulmonary Valve Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Transcatheter Pulmonary Valve Market Size (2019-2030)
9.2 Latin America Transcatheter Pulmonary Valve Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Transcatheter Pulmonary Valve Market Size by Country (2019-2024)
9.4 Latin America Transcatheter Pulmonary Valve Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Transcatheter Pulmonary Valve Market Size (2019-2030)
10.2 Middle East & Africa Transcatheter Pulmonary Valve Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Transcatheter Pulmonary Valve Market Size by Country (2019-2024)
10.4 Middle East & Africa Transcatheter Pulmonary Valve Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Boston Scientific Corporation
11.1.1 Boston Scientific Corporation Company Detail
11.1.2 Boston Scientific Corporation Business Overview
11.1.3 Boston Scientific Corporation Transcatheter Pulmonary Valve Introduction
11.1.4 Boston Scientific Corporation Revenue in Transcatheter Pulmonary Valve Business (2019-2024)
11.1.5 Boston Scientific Corporation Recent Development
11.2 Braile Biomédica
11.2.1 Braile Biomédica Company Detail
11.2.2 Braile Biomédica Business Overview
11.2.3 Braile Biomédica Transcatheter Pulmonary Valve Introduction
11.2.4 Braile Biomédica Revenue in Transcatheter Pulmonary Valve Business (2019-2024)
11.2.5 Braile Biomédica Recent Development
11.3 Direct Flow Medical
11.3.1 Direct Flow Medical Company Detail
11.3.2 Direct Flow Medical Business Overview
11.3.3 Direct Flow Medical Transcatheter Pulmonary Valve Introduction
11.3.4 Direct Flow Medical Revenue in Transcatheter Pulmonary Valve Business (2019-2024)
11.3.5 Direct Flow Medical Recent Development
11.4 Edwards Lifesciences Corporation
11.4.1 Edwards Lifesciences Corporation Company Detail
11.4.2 Edwards Lifesciences Corporation Business Overview
11.4.3 Edwards Lifesciences Corporation Transcatheter Pulmonary Valve Introduction
11.4.4 Edwards Lifesciences Corporation Revenue in Transcatheter Pulmonary Valve Business (2019-2024)
11.4.5 Edwards Lifesciences Corporation Recent Development
11.5 JenaValve Technology, Inc.
11.5.1 JenaValve Technology, Inc. Company Detail
11.5.2 JenaValve Technology, Inc. Business Overview
11.5.3 JenaValve Technology, Inc. Transcatheter Pulmonary Valve Introduction
11.5.4 JenaValve Technology, Inc. Revenue in Transcatheter Pulmonary Valve Business (2019-2024)
11.5.5 JenaValve Technology, Inc. Recent Development
11.6 Abbott
11.6.1 Abbott Company Detail
11.6.2 Abbott Business Overview
11.6.3 Abbott Transcatheter Pulmonary Valve Introduction
11.6.4 Abbott Revenue in Transcatheter Pulmonary Valve Business (2019-2024)
11.6.5 Abbott Recent Development
11.7 SYMETIS (Boston Scientific)
11.7.1 SYMETIS (Boston Scientific) Company Detail
11.7.2 SYMETIS (Boston Scientific) Business Overview
11.7.3 SYMETIS (Boston Scientific) Transcatheter Pulmonary Valve Introduction
11.7.4 SYMETIS (Boston Scientific) Revenue in Transcatheter Pulmonary Valve Business (2019-2024)
11.7.5 SYMETIS (Boston Scientific) Recent Development
11.8 Colibri Heart Valve, LLC
11.8.1 Colibri Heart Valve, LLC Company Detail
11.8.2 Colibri Heart Valve, LLC Business Overview
11.8.3 Colibri Heart Valve, LLC Transcatheter Pulmonary Valve Introduction
11.8.4 Colibri Heart Valve, LLC Revenue in Transcatheter Pulmonary Valve Business (2019-2024)
11.8.5 Colibri Heart Valve, LLC Recent Development
11.9 VENUS MEDTECH
11.9.1 VENUS MEDTECH Company Detail
11.9.2 VENUS MEDTECH Business Overview
11.9.3 VENUS MEDTECH Transcatheter Pulmonary Valve Introduction
11.9.4 VENUS MEDTECH Revenue in Transcatheter Pulmonary Valve Business (2019-2024)
11.9.5 VENUS MEDTECH Recent Development
11.10 XELTIS
11.10.1 XELTIS Company Detail
11.10.2 XELTIS Business Overview
11.10.3 XELTIS Transcatheter Pulmonary Valve Introduction
11.10.4 XELTIS Revenue in Transcatheter Pulmonary Valve Business (2019-2024)
11.10.5 XELTIS Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
